Eurox Hartleys Report | 28 April 2022
Botanix (ASX:BOT) is pleased to share a Quick Comment research report from leading stockbroking firm, Euroz Hartleys, following the Company’s announcement that the US FDA has granted BOT Qualified Infectious Disease Product (QIPD) designation for BTX1801.
